Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Tuesday will be Tom Cech Day throughout the city of Champaign — and the distinguished honoree will be in town for the ...

Enzymes originally evolved in high-temperature environments and later adapted to lower temperatures as Earth cooled. Scientists discovered that a key shift in enzyme function occurred over ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive antibiotic resistance and even shape entire ecosystems. Now an interdisciplinary ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive antibiotic resistance and even shape entire ecosystems.

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Sapablursen, an investigational RNA therapy for polycythemia vera, is in a fully enrolled Phase 2 trial. How to Spot the Market Bottom: Matt Maley has navigated every major market turn in the last ...

A traffic stop in Santa Monica earlier this month led to the discovery of stolen catalytic converters and cutting tools in the trunk of a vehicle, police said over the weekend. Officers pulled the ...